DK2182007T3 - Fremgangsmåde til fremstilling af humant G-CSF - Google Patents

Fremgangsmåde til fremstilling af humant G-CSF

Info

Publication number
DK2182007T3
DK2182007T3 DK10153219.0T DK10153219T DK2182007T3 DK 2182007 T3 DK2182007 T3 DK 2182007T3 DK 10153219 T DK10153219 T DK 10153219T DK 2182007 T3 DK2182007 T3 DK 2182007T3
Authority
DK
Denmark
Prior art keywords
csf
human
preparation
Prior art date
Application number
DK10153219.0T
Other languages
English (en)
Inventor
Sanjeev Kumar Mendiratta
Vibhor Saraswat
Pankaj R Patel
Original Assignee
Cadila Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd
Application granted granted Critical
Publication of DK2182007T3 publication Critical patent/DK2182007T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/68—Stabilisation of the vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
DK10153219.0T 2006-03-06 2007-03-05 Fremgangsmåde til fremstilling af humant G-CSF DK2182007T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN309MU2006 2006-03-06
EP07736565.8A EP1994138B1 (en) 2006-03-06 2007-03-05 Process for preparing human g-csf

Publications (1)

Publication Number Publication Date
DK2182007T3 true DK2182007T3 (da) 2014-04-22

Family

ID=38436804

Family Applications (2)

Application Number Title Priority Date Filing Date
DK07736565.8T DK1994138T3 (da) 2006-03-06 2007-03-05 Fremgangsmåde til fremstilling af humant g-csf
DK10153219.0T DK2182007T3 (da) 2006-03-06 2007-03-05 Fremgangsmåde til fremstilling af humant G-CSF

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK07736565.8T DK1994138T3 (da) 2006-03-06 2007-03-05 Fremgangsmåde til fremstilling af humant g-csf

Country Status (17)

Country Link
US (2) US8021862B2 (da)
EP (2) EP2182007B1 (da)
JP (2) JP4927103B2 (da)
KR (1) KR101176794B1 (da)
CN (2) CN102776261B (da)
AP (2) AP2647A (da)
AU (1) AU2007224331B2 (da)
BR (1) BRPI0707078A2 (da)
CA (1) CA2642654C (da)
DK (2) DK1994138T3 (da)
EA (2) EA022782B1 (da)
MX (1) MX2008011407A (da)
MY (1) MY149168A (da)
NZ (2) NZ596111A (da)
PL (2) PL1994138T3 (da)
WO (1) WO2007102174A2 (da)
ZA (1) ZA200806978B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2201120T3 (pl) 2007-09-21 2014-05-30 Cadila Healthcare Ltd Systemy białek fuzyjnych GCSF odpowiednie do wysokiej ekspresji peptydów
WO2009113099A2 (en) * 2008-02-06 2009-09-17 Biocon Limited Fermentation medias and processes thereof
WO2011086447A2 (en) 2010-01-12 2011-07-21 Lupin Limited Fermentation process for the preparation of recombinant heterologous proteins
CN108103243A (zh) * 2018-01-04 2018-06-01 哈尔滨瀚邦医疗科技有限公司 一种猪乙脑病毒遗传稳定性的检测方法及应用
CN114350588B (zh) * 2021-12-31 2024-03-15 山东新时代药业有限公司 一种rhG-CSF的发酵培养基及其发酵方法
JP2023159784A (ja) * 2022-04-20 2023-11-01 東ソー株式会社 アデノ随伴ウイルス結合性タンパク質の製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9107846D0 (en) * 1990-04-30 1991-05-29 Ici Plc Polypeptides
WO2006067804A2 (en) * 2004-12-20 2006-06-29 Cadila Healthcare Limited Process for preparing high levels of interferon beta

Also Published As

Publication number Publication date
NZ596111A (en) 2012-12-21
NZ571337A (en) 2011-12-22
PL1994138T3 (pl) 2014-08-29
HK1176645A1 (en) 2013-08-02
EP1994138A2 (en) 2008-11-26
AP2647A (en) 2013-04-17
DK1994138T3 (da) 2014-05-12
WO2007102174A3 (en) 2008-01-03
EA201100718A1 (ru) 2012-02-28
JP5460660B2 (ja) 2014-04-02
CA2642654C (en) 2014-04-22
CN102776261A (zh) 2012-11-14
CN101410410B (zh) 2013-06-12
EA200870320A1 (ru) 2009-02-27
ZA200806978B (en) 2009-05-27
JP4927103B2 (ja) 2012-05-09
MY149168A (en) 2013-07-31
AP2008004592A0 (en) 2008-08-31
US8021862B2 (en) 2011-09-20
EP2182007A1 (en) 2010-05-05
CA2642654A1 (en) 2007-09-13
KR101176794B1 (ko) 2012-08-24
EP1994138B1 (en) 2014-04-30
BRPI0707078A2 (pt) 2011-04-19
US20090305354A1 (en) 2009-12-10
CN102776261B (zh) 2014-09-24
JP2009528836A (ja) 2009-08-13
HK1127617A1 (en) 2009-10-02
EA015498B1 (ru) 2011-08-30
AP2012006440A0 (en) 2012-08-31
US8492120B2 (en) 2013-07-23
WO2007102174A2 (en) 2007-09-13
AU2007224331A1 (en) 2007-09-13
AP3142A (en) 2015-02-28
CN101410410A (zh) 2009-04-15
MX2008011407A (es) 2008-09-24
US20110070611A1 (en) 2011-03-24
JP2011229541A (ja) 2011-11-17
PL2182007T3 (pl) 2014-06-30
EA022782B1 (ru) 2016-03-31
EP2182007B1 (en) 2014-03-05
KR20080104011A (ko) 2008-11-28
AU2007224331B2 (en) 2011-05-26

Similar Documents

Publication Publication Date Title
DK2086944T3 (da) Fremgangsmåde til fremstilling af difluormethylpyrazolylcarboxylater
DK2504005T3 (da) Anvendelse af 1,3-diphenylprop-2-en-1-on-derivater til behandling af lever-sygdomme
DK2474321T3 (da) Sammensætninger til behandling af collagenmedierede sygdomme
DK2046767T3 (da) Fremgangsmåde til fremstilling af diaminophenothiaziniumforbindelser
DK1874781T3 (da) Dihydrothienopyrimidiner til behandling af inflammatoriske sygdomme
DK2478907T3 (da) Sammensætninger til behandling af kræft
PL3354276T3 (pl) Kompozycje do leczenia zapalenia przewodu pokarmowego
DK2114886T3 (da) Fremgangsmåde til fremstilling af visse substituerede sulfiliminer
DK1893586T3 (da) Fremgangsmåde til fremstilling af 1-alkyl-3-phenyluraciler
DK1828164T3 (da) Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider
DK1778668T3 (da) Fremgangsmåde til fremstilling af dihydropteridion
DK3456707T3 (da) 4-(p-quinonyl)-2-hydroxybutanamidderivater til behandling af mitokondriesygdomme
SMAP200900085A (it) 3-imidazolil-indoli per il trattamento di malattieproliferative
DK3289876T3 (da) Forbindelser til behandling af cancer
DK2056842T3 (da) Modificeret galactosylceramid til behandling af cancerøse sygdomme
DK2209900T3 (da) Anvendelse af bakterier til fremstillingen af bioenergi
NO20076030L (no) Fremgangsmåte for fremstilling av hydroklorsilaner
DK2285808T3 (da) Spiroindolderivater til behandling af parasitsygdomme
DK2209784T3 (da) Forbindelser til behandling af hepatitis C
DK2382232T3 (da) Fremgangsmåde til fremstilling af bivalirudin
PL2205720T3 (pl) Kompozycja do leczenia stwardnienia rozsianego
DK2117565T3 (da) Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme
DK2296651T3 (da) 5-hydroxymethyl-oxazolidin-2-on-derivater til behandling af bakterielle intestinale sygdomme
DK2182007T3 (da) Fremgangsmåde til fremstilling af humant G-CSF
DK2285416T3 (da) Konjugat til behandlingen af mesotheliom